Sinchita Roy Chowdhuri, M.D., Ph.D.

Peer-Reviewed Articles

1. Yang, RK, Rashid, A, Roy Chowdhuri, S, Hong, DS, Bryan, J. Clinicopathological features and outcomes for colorectal carcinomas with KRAS codon 146 mutations. ESMO Gastrointestinal Oncology 10, 2025. e-Pub 2025.
2. Hong, L, Di Federico, A, Liu, B, Cooper, AJ, Alessi, JV, Clark, P, Rinsurongkawong, W, Young, C, Li, H, Qin, K, Aminu, M, Santo, V, Elamin, YY, Sepesi, B, Lewis, J, Gibbons, DL, Vaporciyan, AA, Lee, JJ, Le, X, Wu, J, Roy Chowdhuri, S, Routbort, MJ, Futreal, PA, Heymach, JV, Awad, MM, Schoenfeld, AJ, Zhang, J, Ricciuti, B, Deng, L, Vokes, N. Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma. Journal of Thoracic Oncology 20(12):1763-1777, 2025. e-Pub 2025. PMID: 40716572.
3. Roy Chowdhuri, S, Booth, CN, Heymann, JJ, Jenkins, E, Menke, JR, Monaco, SE, Nayar, R, Nishino, M, Ruiz-Cordero, R, Russell, DK, Saqi, A, Sundling, KE, Thrall, MJ, Torous, V, VandenBussche, CJ, Zhang, ML, Siddiqui, MT, VanderLaan, PA. Optimizing cytology and small biopsy specimen processing for ancillary studies. Journal of the American Society of Cytopathology 14(5):285-308, 2025. e-Pub 2025. PMID: 40754479.
4. Shen Y, Zheng L, Zhao J, Wang Y, Chen H, Roy-Chowdhuri S, Kamat AM, Alhalabi O, Gao J, Siefker-Radtke A, Wei P, Hansel DE, Czerniak B, Guo CC. Molecular profile of micropapillary urothelial carcinoma of the urinary bladder: An analysis of 99 cases by next-generation sequencing. Hum Pathol 159:105812, 2025. e-Pub 2025. PMID: 40403852.
5. Maher, MH, Treekitkarnmongkol, W, Ghatak, S, Dai, J, Liu, S, Nguyen, T, Duose, D, Kim, M, Hu, T, Hurd, MW, Paris, PL, Kirkwood, K, Maitra, A, Luthra, R, Sen, S, Roy Chowdhuri, S. An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid. Cancer Cytopathology 133(4), 2025. e-Pub 2025. PMID: 40106268.
6. Acanfora G, Iaccarino A, Cerbelli B, Di Cristofano C, Bellevicine C, Barberis M, Bonoldi E, Bubendorf L, Calaminus A, Campione S, Canberk S, Cavazza A, Cazzaniga G, Chijioke O, Clery E, Eccher A, Engels M, Fiorentino V, Graziano P, Kern I, Kholova I, Laatta J, Labiano T, Leopizzi M, Lozano MD, Luis R, Maffei E, Marando A, Martini M, Merenda E, Montella M, Morales AA, Nishino M, Pagni F, Hofman P, Pernazza A, Roy-Chowdhuri S, Saieg M, Savic Prince S, Siddiqui MT, Stoos-Veic T, Strojan Flezar M, Sundov D, VanderLaan P, Vrdoljak-Mozetic D, Zeppa P, Troncone G, Vigliar E. InterobServer AgreeMent in Pd-l1 evaLuatIoN on cytoloGical samples-SAMPLING project: A multi-institutional, international study. Cancer Cytopathol 133(3):e70003, 2025. e-Pub 2025. PMID: 39992702.
7. Wang P, Yang RK, Jelloul FZ, Luthra R, Routbort MJ, Chen H, Loghavi S, Ok CY, Kanagal-Shamanna R, Roy-Chowdhuri S, Medeiros LJ, Patel KP. Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time. JCO Precis Oncol 9:e2400299, 2025. e-Pub 2025. PMID: 40138600.
8. Marczyk, VR, Fazeli, S, Dadu, R, Busaidy, NL, Iyer, PC, Hu, MI, Sherman, SI, Hamidi, S, Hosseini, SM, Williams, MD, Ahmed, S, Routbort, MJ, Luthra, R, Roy Chowdhuri, S, San Lucas, FA, Patel, KP, Hong, DS, Zafereo, M, Wang, RJ, Maniakas, A, Waguespack, SG, Cabanillas, ME. NTRK Fusion-Positive Thyroid Carcinoma. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 39983078.
9. Yang, RK, Alvarez, HA, Lucas, AS, Roy Chowdhuri, S, Rashid, A, Chen, H, Ballester, L, Sweeney, K, Routbort, MJ, Patel, KP, Luthra, R, Medeiros, LJ, Toruner, GA. Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistry. Cancer Genetics 290-291:44-50, 2025. e-Pub 2025. PMID: 39700818.
10. Iorgulescu, JB, Yang, RK, Roy Chowdhuri, S, Sura, GH. Same-day molecular testing for targetable mutations in solid tumor cytopathology—The next frontier of the rapid on-site evaluation. Cancer Cytopathology 133(1), 2025. e-Pub 2025. PMID: 39746874.
11. Maher, MH, Duose, D, Wistuba, II, Luthra, R, Arjuna, S, Roy Chowdhuri, S. A rapid turnaround time workflow for a cytological liquid biopsy assay using FNA supernatant specimens. Cancer Cytopathology 133(1), 2025. e-Pub 2025. PMID: 39704279.
12. Yang RK, Alvarez H, Lucas AS, Roy-Chowdhuri S, Rashid A, Chen H, Ballester LY, Sweeney K, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Toruner GA. Microsatellite instability and high tumor mutational burden detected by next generation sequencing are concordant with loss of mismatch repair proteins by immunohistochemistry. Cancer Genet 290-291:44-50, 2025. e-Pub 2025. PMID: 39700818.
13. Heymann JJ, Pineda CM, Booth CN, Jenkins E, Menke JR, Monaco SE, Nayar R, Nishino M, Roy-Chowdhuri S, Ruiz-Cordero R, Russell DK, Saqi A, Sundling KE, Thrall MJ, Torous VF, VandenBussche CJ, VanderLaan PA, Zhang ML, Siddiqui MT. Tools, techniques, and challenges in preparing cytology specimens for ancillary studies: results of the ASC Optimizing Cytology and Small Biopsy Specimen Processing for Ancillary Studies task force survey. J Am Soc Cytopathol 14(1):55-63, 2025. e-Pub 2025. PMID: 39547835.
14. Desai A, Subbiah V, Roy-Chowdhuri S, Sheshadri A, Deshmukh S, Peters S. Association of Antibody-Drug Conjugate (ADC) Target Expression and Interstitial Lung Disease (ILD) in Non-Small-Cell Lung Cancer (NSCLC): Association or Causation or Neither?. Cancers (Basel) 16(22), 2024. e-Pub 2024. PMID: 39594708.
15. Roy-Chowdhuri S, Mani H, Fox AH, Tsao A, Sholl LM, Farjah F, Johnson BE, Osarogiagbon RU, Rivera MP, Silvestri GA, Smith RA, Wistuba II. The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non-small cell lung cancer. Cancer, 2024. e-Pub 2024. PMID: 39347608.
16. Roy-Chowdhuri S. The updated College of American Pathologists principles of analytic validation of immunohistochemical assays: A step forward for cytopathology. Cancer Cytopathol 132(9):547-548, 2024. e-Pub 2024. PMID: 38536199.
17. Macy ME, Mody R, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Williams PM, Patton DR, Coffey BD, Roy-Chowdhuri S, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I). JCO Precis Oncol 8:e2400418, 2024. e-Pub 2024. PMID: 39298716.
18. Laetsch TW, Ludwig K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Mhlanga J, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D. JCO Precis Oncol 8:e2400258, 2024. e-Pub 2024. PMID: 39298693.
19. Nelson MV, Kim A, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G. Oncologist 29(8):e723-e1093, 2024. e-Pub 2024. PMID: 38873934.
20. Glade Bender JL, Pinkney K, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial. Oncologist 29(7):638-e952, 2024. e-Pub 2024. PMID: 38815151.
21. Vigliar, E, Bellevicine, C, Acanfora, G, Morales, AA, Carillo, AM, Cozzolino, D, Nacchio, M, Luca, CD, Pisapia, P, Lozano, MD, Roy Chowdhuri, S, Troncone, G. How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases. Journal of Molecular Pathology 5(2):228-237, 2024. e-Pub 2024.
22. Vo KT, Sabnis AJ, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Jaju A, Fox E, Weigel BJ, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Phase II Study of Ulixertinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. JCO Precis Oncol 8:e2400103, 2024. e-Pub 2024. PMID: 38935895.
23. Zheng, L, Chen, H, Zhao, J, Roy Chowdhuri, S, Kamat, A, Alhalabi, O, Gao, J, Siefker-Radtke, AO, Hansel, DE, Czerniak, BA, Guo, C. Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases 148:1-6, 2024. e-Pub 2024. PMID: 38679207.
24. Laberiano-Fernandez C, Gan Q, Wang SM, Tamegnon A, Wistuba I, Yoon E, Roy-Chowdhuri S, Parra ER. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma. J Am Soc Cytopathol 13(3):161-173, 2024. e-Pub 2024. PMID: 38519275.
25. Chen-Yost, HI, Bammert, CE, Hao, W, Heymann, JJ, Lin, D, Marotti, JD, Waraksa-Deutsch, T, Huang, M, Krishnamurti, U, Lin, O, Ly, A, Moatamed, N, Pantanowitz, L, Roy Chowdhuri, S. Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023 13(3):194-204, 2024. e-Pub 2024. PMID: 38582697.
26. Zheng L, Chen H, Zhao J, Roy-Chowdhuri S, Kamat AM, Alhalabi O, Gao J, Siefker-Radtke A, Hansel DE, Czerniak B, Guo CC. Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases 148:1-6. e-Pub 2024. PMID: 38679207.
27. Goldsmith JD, Troxell ML, Roy-Chowdhuri S, Colasacco CF, Edgerton ME, Fitzgibbons PL, Fulton R, Haas T, Kandalaft PL, Kalicanin T, Lacchetti C, Loykasek P, Thomas NE, Swanson PE, Bellizzi AM. Principles of Analytic Validation of Immunohistochemical Assays: Guideline Update. e-Pub 2024. PMID: 38391878.
28. Arjuna S, Shah M, Dono A, Nunez-Rubiano L, Pichardo-Rojas PS, Zhu JJ, Riascos RF, Luthra R, Roy-Chowdhuri S, Duose D, Wang DH, Lang FF, Esquenazi Y, Ballester LY. Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer. J Neurooncol 166(1):39-49, 2024. e-Pub 2024. PMID: 38160230.
29. Goldsmith, J, Troxell, ML, Roy Chowdhuri, S, Colasacco, C, Edgerton, ME, Fitzgibbons, PL, Fulton, R, Haas, T, Kandalaft, PL, Kalicanin, T, Lacchetti, C, Loykasek, P, Thomas, NE, Swanson, PE, Bellizzi, AM. Principles of Analytic Validation of Immunohistochemical Assays. Archives of Pathology and Laboratory Medicine 148(6):e111-e153, 2024. e-Pub 2024. PMID: 38391878.
30. Zheng L, Luthra R, Alvarez HA, San Lucas FA, Duose DY, Wistuba II, Fuller GN, Ballester LY, Roy-Chowdhuri S, Sweeney KJ, Rashid A, Yang RK, Chen W, Liu A, Wu Y, Albarracin C, Patel KP, Routbort MJ, Sahin AA, Ding Q, Chen H. Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors. Cancers (Basel) 16(1), 2024. e-Pub 2024. PMID: 38201434.
31. Diks J, Tang Z, Altan M, Anderson S, Chen H, Rashid A, Yang RK, Routbort MJ, Patel KP, Toruner GA, Medeiros LJ, Tang G, Luthra R, Roy-Chowdhuri S. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization. Cancer Cytopathol 132(1):41-49, 2024. e-Pub 2024. PMID: 37747438.
32. Badgwell B, Estrella J, Roy-Chowdhuri S, Ikoma N, Blum Murphy M, Ajani J, Mansfield P. Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer. e-Pub 2024. PMID: 38286882.
33. Chen-Yost HI, Bammert C, Hao W, Heymann JJ, Lin DM, Marotti J, Waraksa-Deutsch T, Huang M, Krishnamurti U, Lin O, Ly A, Moatamed N, Pantanowitz L, Roy-Chowdhuri S. Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023 13(3):194-204, 2024. e-Pub 2024. PMID: 38582697.
34. Hong L, Aminu M, Li S, Lu X, Petranovic M, Saad MB, Chen P, Qin K, Varghese S, Rinsurongkawong W, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Gandhi SJ, Lin SH, Lee PP, Carter BW, Wu CC, Antonoff MB, Sepesi B, Lewis J, Gibbons DL, Vaporciyan AA, Le X, Jack Lee J, Roy-Chowdhuri S, Routbort MJ, Gainor JF, Heymach JV, Lou Y, Wu J, Zhang J, Vokes NI. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer. Nat Commun 14(1):695, 2023. e-Pub 2023. PMID: 36755027.
35. Chi SN, Yi JS, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey BD, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Mhlanga JC, Fox E, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Tazemetostat for Tumors Harboring SMARCB1/SMARCA4 or EZH2 Alterations: Results from NCI-COG Pediatric MATCH APEC1621C. J Natl Cancer Inst 115(11):1355-1363, 2023. e-Pub 2023. PMID: 37228094.
36. Wang K, Du R, Roy-Chowdhuri S, Li ZT, Hong L, Vokes N, Elamin YY, Hume CB, Skoulidis F, Gay CM, Blumenschein G, Fossella FV, Tsao A, Zhang J, Karachaliou N, O'Brate A, Gann CN, Lewis J, Rinsurongkawong W, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Altan M, Le X. Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC. JTO Clin Res Rep 4(8):100533, 2023. e-Pub 2023. PMID: 37649681.
37. Malapelle U, Pepe F, Pisapia P, Altimari A, Bellevicine C, Brunnström H, Bruno R, Büttner R, Cirnes L, De Andrea CE, de Biase D, Dumur CI, Ericson Lindquist K, Fontanini G, Gautiero E, Gentien D, Hofman P, Hofman V, Iaccarino A, Lozano MD, Mayo-de-Las-Casas C, Merkelbach-Bruse S, Pagni F, Roman R, Schmitt FC, Siemanowski J, Roy-Chowdhuri S, Tallini G, Tresserra F, Vander Borght S, Vielh P, Vigliar E, Vita GAC, Weynand B, Rosell R, Molina Vila MA, Troncone G. Reference standards for gene fusion molecular assays on cytological samples: an international validation study. J Clin Pathol 76(1):47-52, 2023. e-Pub 2023. PMID: 34429353.
38. Garcia A, Rivera Rolon MDM, Barkoh B, Chen W, Luthra R, Roy-Chowdhuri S. Assessment of BRAF V600E (VE1) immunochemistry for the detection of BRAF V600E mutation in non-small cell lung carcinoma cytology specimens. Cancer Cytopathol 131(1):50-57, 2023. e-Pub 2023. PMID: 36200799.
39. Roy-Chowdhuri S, Davies KD, Ritterhouse LL, Snow AN. ERBB2 (HER2) Alterations in Colorectal Cancer. J Mol Diagn 24(10):1064-1066, 2022. e-Pub 2022. PMID: 35944596.
40. Yang RK, Chen H, Roy-Chowdhuri S, Rashid A, Alvarez H, Routbort M, Patel KP, Luthra R, Medeiros LJ, Toruner GA. Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods. Cancers (Basel) 14(19), 2022. e-Pub 2022. PMID: 36230473.
41. *Faber E, Grosu H, Sabir S, San Lucas FA, Barkoh BA, Bassett RL, Luthra R, Stewart J, Roy-Chowdhuri S. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy. J Clin Pathol 75(9):612-619, 2022. e-Pub 2022. PMID: 33952592.
42. Zaleski MP, Chen H, Roy-Chowdhuri S, Patel KP, Luthra R, Routbort MJ, Kamat AM, Gao J, Siefker-Radtke A, Czerniak B, Guo CC. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma. Am J Clin Pathol 158(2):263-269, 2022. e-Pub 2022. PMID: 35467000.
43. Vigliar E, Pisapia P, Dello Iacovo F, Alcaraz-Mateos E, Alì G, Ali SZ, Baloch ZW, Bellevicine C, Bongiovanni M, Botsun P, Bruzzese D, Bubendorf L, Büttner R, Canberk S, Capitanio A, Casadio C, Cazacu E, Cochand-Priollet B, D'Amuri A, Davis K, Eloy C, Engels M, Fadda G, Fontanini G, Fulciniti F, Hofman P, Iaccarino A, Ieni A, Jiang XS, Kakudo K, Kern I, Kholova I, Linton McDermott KM, Liu C, Lobo A, Lozano MD, Malapelle U, Maleki Z, Michelow P, Mikula MW, Musayev J, Özgün G, Oznur M, Peiró Marqués FM, Poller D, Pyzlak M, Robinson B, Rossi ED, Roy-Chowdhuri S, Saieg M, Savic Prince S, Schmitt FC, Seguí Iváñez FJ, Štoos-Veic T, Sulaieva O, Sweeney BJ, Tuccari G, van Velthuysen ML, VanderLaan PA, Vielh P, Viola P, Voorham QJM, Weynand B, Zeppa P, Faquin WC, Pitman MB, Troncone G. COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study. Cancer Cytopathol 130(5):344-351, 2022. e-Pub 2022. PMID: 35006650.
44. Gan Q, Roy-Chowdhuri S, Duose DY, Stewart JM, Coronel E, Bhutani MS, Lee JH, Weston B, Ge PS, Ross WA, Maitra A. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB. Cancer Cytopathol 130(4):275-283, 2022. e-Pub 2022. PMID: 34905283.
45. *Dinarvand P, Wang WL, Roy-Chowdhuri S. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations. Cytopathology 33(2):216-221, 2022. e-Pub 2022. PMID: 34816516.
46. Liu Z, Williams M, Stewart J, Glisson BS, Fuller C, Roy-Chowdhuri S. Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma. Cancer Cytopathol 130(2):110-119, 2022. e-Pub 2022. PMID: 34375025.
47. Eckstein OS, Allen CE, Williams PM, Roy-Chowdhuri S, Patton DR, Coffey B, Reid JM, Piao J, Saguilig L, Alonzo TA, Berg SL, Ramirez NC, Jaju A, Mhlanga J, Fox E, Hawkins DS, Mooney MM, Takebe N, Tricoli JV, Janeway KA, Seibel NL, Parsons DW. Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial. J Clin Oncol 40(20):2235-2245, 2022. e-Pub 2022. PMID: 35363510.
48. Parsons DW, Janeway KA, Patton DR, Winter CL, Coffey B, Williams PM, Roy-Chowdhuri S, Tsongalis GJ, Routbort M, Ramirez NC, Saguilig L, Piao J, Alonzo TA, Berg SL, Fox E, Hawkins DS, Abrams JS, Mooney M, Takebe N, Tricoli JV, Seibel NL, MATCH Team NP. Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial. J Clin Oncol 40(20):2224-2234, 2022. e-Pub 2022. PMID: 35353553.
49. Rudzinski ER, Hechtman J, Roy-Chowdhuri S, Rudolph M, Lockwood CM, Silvertown J, Wierzbinska J, Shen K, Norenberg R, Nogai H, Hong DS, Drilon A, Laetsch TW. Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib. Cancer Genet 260-261:46-52, 2022. e-Pub 2022. PMID: 34929613.
50. Song S, Xu Y, Huo L, Zhao S, Wang R, Li Y, Scott AW, Pizzi MP, Wang Y, Fan Y, Harada K, Jin J, Ma L, Yao X, Shanbhag ND, Gan Q, Roy-Chowdhuri S, Badgwell BD, Wang Z, Wang L, Ajani JA. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma. J Exp Clin Cancer Res 40(1):207, 2021. e-Pub 2021. PMID: 34162421.
51. Coleman N, Subbiah V, Pant S, Patel K, Roy-Chowdhuri S, Yedururi S, Johnson A, Yap TA, Rodon J, Shaw K, Meric-Bernstam F. Emergence of mTOR mutation as an acquired resistance mechanism to AKT inhibition, and subsequent response to mTORC1/2 inhibition. NPJ Precis Oncol 5(1):99, 2021. e-Pub 2021. PMID: 34853384.
52. *Ramani NS, Patel KP, Routbort MJ, Alvarez H, Broaddus R, Chen H, Rashid A, Lazar A, San Lucas FA, Yao H, Manekia J, Dang H, Barkoh BA, Medeiros LJ, Luthra R, Roy-Chowdhuri S. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing. Arch Pathol Lab Med 145(11):1405-1412, 2021. e-Pub 2021. PMID: 33493304.
53. Hao D, He S, Harada K, Pizzi MP, Lu Y, Guan P, Chen L, Wang R, Zhang S, Sewastjanow-Silva M, Abdelhakeem A, Shanbhag N, Bhutani M, Han G, Lee JH, Zhao S, Weston B, Blum Murphy M, Waters R, Estrella JS, Roy-Chowdhuri S, Gan Q, Lee JS, Peng G, Hanash SM, Calin GA, Song X, Zhang J, Song S, Wang L, Ajani JA. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma. Gut 70(11):2055-2065, 2021. e-Pub 2021. PMID: 33334899.
54. *Peyman D, Liu C, Roy-Chowdhuri S. A decade of change: Trends in the practice of cytopathology at a tertiary care cancer centre. Cytopathology 32(5):604-610, 2021. e-Pub 2021. PMID: 33792972.
55. Cazacu IM, Semaan A, Stephens B, Swartzlander DB, Guerrero PA, Singh BS, Lungulescu CV, Danciulescu MM, Cherciu Harbiyeli IF, Streata I, Popescu C, Saftoiu A, Roy-Chowdhuri S, Maitra A, Bhutani MS. Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA. Gastrointest Endosc 93(5):1142-1151.e2, 2021. e-Pub 2020. PMID: 33058885.
56. *Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, Tang Z, Bassett R, Manekia J, Barkoh BA, Dang H, Roy-Chowdhuri S. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers. Cancer Cytopathol 129(5):374-382, 2021. e-Pub 2021. PMID: 33119213.
57. Miller DL, Ribeiro EA, Roy-Chowdhuri S, Illei PB, Siddiqui MT, Ali SZ. Renal medullary carcinoma involving serous cavity fluids: a cytomorphologic study of 12 cases. J Am Soc Cytopathol 10(2):187-196, 2021. e-Pub 2021. PMID: 32651128.
58. Shah M, Takayasu T, Zorofchian Moghadamtousi S, Arevalo O, Chen M, Lan C, Duose D, Hu P, Zhu JJ, Roy-Chowdhuri S, Riascos RF, Chen H, Luthra R, Esquenazi Y, Ballester LY. Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies. J Mol Diagn 23(2):171-180, 2021. e-Pub 2021. PMID: 33531134.
59. Dutta R, Nambirajan A, Mittal S, Roy-Chowdhuri S, Jain D. Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations. Cancer Cytopathol 129(1):53-61, 2021. e-Pub 2021. PMID: 32877005.
60. Xu M, Tapia C, Hajjar J, Sabir S, Colen R, Nagarajan P, Aung PP, Gong J, Rodon J, Fu S, Stephen B, Roy-Chowdhuri S, Le H, Yang V, Zarifa A, Abdelsalam ME, Jhingran A, Javle M, Pant S, Carter B, Milton DR, Sun R, Karp DD, Koay EJ, Yang Y, Wistuba II, Hwu P, Meric-Bernstam F, Naing A. Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens. J Immunother Precis Oncol 4(2):45-52, 2021. e-Pub 2021. PMID: 35663531.
61. Ajani JA, Xu Y, Huo L, Wang R, Li Y, Wang Y, Pizzi MP, Scott A, Harada K, Ma L, Yao X, Jin J, Zhao W, Dong X, Badgwell BD, Shanbhag N, Tatlonghari G, Estrella JS, Roy-Chowdhuri S, Kobayashi M, Vykoukal JV, Hanash SM, Calin GA, Peng G, Lee JS, Johnson RL, Wang Z, Wang L, Song S. YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition. Gut 70(1):55-66, 2021. e-Pub 2021. PMID: 32345613.
62. *Hou T, Landon G, Stewart J, Roy-Chowdhuri S. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions. Cancer Cytopathol 129(1):75-82, 2021. e-Pub 2021. PMID: 32809259.
63. Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Abdelhakeem AAF, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal A, Song S, Ajani JA, Wang L. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat Med 27(1):141-151, 2021. e-Pub 2021. PMID: 33398161.
64. *Jacobi EM, Landon G, Broaddus RR, Roy-Chowdhuri S. Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy. Arch Pathol Lab Med 145(1):46-54, 2021. e-Pub 2021. PMID: 33367660.
65. Badgwell B, Ikoma N, Murphy MB, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky BD, Lano E, Song S, Mansfield P, Ajani J. A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology. Ann Surg Oncol 28(1):258-264, 2021. e-Pub 2021. PMID: 32556731.
66. Miller DL, Roy-Chowdhuri S, Illei P, James A, Hruban RH, Ali SZ. Primary pancreatic Ewing sarcoma: a cytomorphologic and histopathologic study of 13 cases. J Am Soc Cytopathol 9(6):502-512, 2020. e-Pub 2020. PMID: 32536453.
67. Cazacu IM, Singh BS, Luzuriaga Chavez AA, Koduru P, Ejaz S, Weston BR, Ross WA, Lee JH, Roy-Chowdhuri S, Bhutani MS. EUS and EUS-guided FNA/core biopsies in the evaluation of subepithelial lesions of the lower gastrointestinal tract: 10-year experience. Endosc Ultrasound 9(5):329-336, 2020. e-Pub 2020. PMID: 32913150.
68. Blum Murphy M, Ikoma N, Wang X, Estrella J, Roy-Chowdhuri S, Das P, Minsky BD, Song S, Mansfield P, Ajani J, Badgwell B. Phase I Trial of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) with Cisplatin, Mitomycin, and Paclitaxel in Patients with Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology. Ann Surg Oncol 27(8):2806-2811, 2020. e-Pub 2020. PMID: 31974712.
69. Srinivasan A, Chowdhuri SR, Grosu HB. Pleural Amyloid as a Cause of Symptomatic Effusion. J Bronchology Interv Pulmonol 27(3):e45-e47, 2020. e-Pub 2020. PMID: 31972693.
70. Tang Z, Chen H, Hong L, Tang G, Toruner GA, Wang W, Roy Chowdhuri S, Yin W, Jung HS, Gu J, Routbort MJ, Zhang J, Khoury JD, Medeiros LJ. Inconsistent Intersample ALK FISH Results in Patients with Lung Cancer: Analysis of Potential Causes. Cancers (Basel) 12(7), 2020. e-Pub 2020. PMID: 32674491.
71. Hariri LP, Smith ML, Mino-Kenudson M, Allen TC, Attanoos R, Borczuk A, Burke L, Cagle PT, Capelozzi V, Dacic S, Guinee D, Raparia K, Roden AC, Roy-Chowdhuri S, Sholl LM, Beasley MB, Churg A. Pulmonary Pathology Society Perspective on the 2018 American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society (ATS/ERS/JRS/ALAT) Idiopathic Pulmonary Fibrosis Clinical Practice Guidelines. Ann Am Thorac Soc 17(5):550-554, 2020. e-Pub 2020. PMID: 31945306.
72. Roy-Chowdhuri S, Dacic S, Ghofrani M, Illei PB, Layfield LJ, Lee C, Michael CW, Miller RA, Mitchell JW, Nikolic B, Nowak JA, Pastis NJ, Rauch CA, Sharma A, Souter L, Billman BL, Thomas NE, VanderLaan PA, Voss JS, Wahidi MM, Yarmus LB, Gilbert CR. Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline From the College of American Pathologists in Collaboration With the American College of Chest Physicians, Association for Molecular Pathology, American Society of Cytopathology, American Thoracic Society, Pulmonary Pathology Society, Papanicolaou Society of Cytopathology, Society of Interventional Radiology, and Society of Thoracic Radiology. Arch Pathol Lab Med. e-Pub 2020. PMID: 32401054.
73. Tapia C, Aung PP, Roy-Chowdhuri S, Xu M, Ouyang F, Alshawa A, Hajjar J, Singh G, Yang V, Castillo L, Le H, Murthy R, Stephen B, Hess KR, Wistuba I, Naing A. Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors. J Immunother Cancer 8(1), 2020. e-Pub 2020. PMID: 32303619.
74. Allen CJ, Blumenthaler AN, Das P, Minsky BD, Blum M, Roy-Chowdhuri S, Ajani JA, Ikoma N, Mansfield PF, Badgwell BD. Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma. World J Surg Oncol 18(1):39, 2020. e-Pub 2020. PMID: 32066454.
75. Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JA. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 69(1):18-31, 2020. e-Pub 2020. PMID: 31171626.
76. *Ruiz-Cordero R, Ma J, Khanna A, Lyons G, Rinsurongkawong W, Bassett R, Guo M, Routbort MJ, Zhang J, Skoulidis F, Heymach J, Roarty EB, Tang Z, Medeiros LJ, Patel KP, Luthra R, Roy-Chowdhuri S. Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations. BMC Cancer 20(1):83, 2020. e-Pub 2020. PMID: 32005111.
77. *Nizamaddin SK, Mehrotra M, Nadhim ASH, Luthra R, Roy-Chowdhuri S. Detection of EGFR T790M Mutation by Droplet Digital Polymerase Chain Reaction in Lung Carcinoma Cytology Samples. Arch Pathol Lab Med. e-Pub 2020. PMID: 31904278.
78. Lepe M, Oltulu P, Canepa M, Wu RI, Deeken A, Alex D, Dinares C, Doxtader EE, Fitzhugh VA, Gibier JB, Jain D, Janaki N, Jelinek A, Labiano T, L'Imperio V, Michael C, Mukhopadhyay S, Pagni F, Panizo A, Pijuan L, Quintana LM, Roy-Chowdhuri S, Sanchez-Font A, Sansano I, Sauter J, Skipper D, Spruill LS, Torous V, Gardner JM, Jiang XS. #EBUSTwitter: Novel Use of Social Media for Conception, Coordination, and Completion of an International, Multicenter Pathology Study. Arch Pathol Lab Med. e-Pub 2019. PMID: 31846366.
79. Grosu HB, Arriola A, Stewart J, Ma J, Bassett R, Hernandez M, Ost D, Roy-Chowdhuri S. PD-L1 detection in histology specimens and matched pleural fluid cell blocks of patients with NSCLC. Respirology 24(12):1198-1203, 2019. e-Pub 2019. PMID: 31209954.
80. Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky BD, Blum M, Song S, Ajani J, Ikoma N, Mansfield PF, Roy-Chowdhuri S, Badgwell BD. Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer. J Surg Oncol 120(8):1350-1357, 2019. e-Pub 2019. PMID: 31612494.
81. Cheung CC, Barnes P, Bigras G, Boerner S, Butany J, Calabrese F, Couture C, Deschenes J, El-Zimaity H, Fischer G, Fiset PO, Garratt J, Geldenhuys L, Gilks CB, Ilie M, Ionescu D, Lim HJ, Manning L, Mansoor A, Riddell R, Ross C, Roy-Chowdhuri S, Spatz A, Swanson PE, Tron VA, Tsao MS, Wang H, Xu Z, Torlakovic EE, (CAP-ACP NSCHCT) CAOPCDPNSCFHCT. Fit-For-Purpose PD-L1 Biomarker Testing For Patient Selection in Immuno-Oncology: Guidelines For Clinical Laboratories From the Canadian Association of Pathologists-Association Canadienne Des Pathologistes (CAP-ACP). Appl Immunohistochem Mol Morphol 27(10):699-714, 2019. e-Pub 2019. PMID: 31584451.
82. Srinivasan A, Iliescu G, Chowdhuri SR, Grosu HB. Follicular Thyroid Carcinoma Presenting as a Large Rib Metastasis. J Bronchology Interv Pulmonol 26(4):e67-e68, 2019. e-Pub 2019. PMID: 31569109.
83. Kudo Y, Haymaker C, Zhang J, Reuben A, Duose DY, Fujimoto J, Roy-Chowdhuri S, Solis Soto LM, Dejima H, Parra ER, Mino B, Abraham R, Ikeda N, Vaporcyan A, Gibbons D, Zhang J, Lang FF, Luthra R, Lee JJ, Moran C, Huse JT, Kadara H, Wistuba II. Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer. Ann Oncol 30(9):1521-1530, 2019. e-Pub 2019. PMID: 31987408.
84. Hasan SN, Sharma A, Ghosh S, Hong SW, Roy-Chowdhuri S, Im SH, Kang K, Rudra D. Bcl11b prevents catastrophic autoimmunity by controlling multiple aspects of a regulatory T cell gene expression program. Sci Adv 5(8):eaaw0706, 2019. e-Pub 2019. PMID: 31457081.
85. *Hannigan B, Ye W, Mehrotra M, Lam V, Bolivar A, Zalles S, Barkoh BA, Duose D, Hu PC, Broaddus R, Stewart J, Heymach J, Medeiros LJ, Wistuba I, Luthra R, Roy-Chowdhuri S. Liquid Biopsy Assay for Lung Carcinoma Using Centrifuged Supernatants from Fine Needle Aspiration Specimens. Ann Oncol 30(6):963-969, 2019. e-Pub 2019. PMID: 30887015.
86. Pisapia P, Malapelle U, Roma G, Saddar S, Zheng Q, Pepe F, Bruzzese D, Vigliar E, Bellevicine C, Luthra R, Nikiforov YE, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Bihl M, Savic S, Bubendorf L, de Biase D, Tallini G, Hwang DH, Sholl LM, Vander Borght S, Weynand B, Stieber D, Vielh P, Rappa A, Barberis M, Fassan M, Rugge M, De Andrea CE, Lozano MD, Lupi C, Fontanini G, Schmitt F, Dumur CI, Bisig B, Bongiovanni M, Merkelbach-Bruse S, Büttner R, Nikiforova MN, Roy-Chowdhuri S, Troncone G, Meeting Group MC. Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens. Cancer Cytopathol 127(5):285-296, 2019. e-Pub 2019. PMID: 31021538.
87. *Ye W, Hannigan B, Zalles S, Mehrotra M, Barkoh BA, Williams MD, Cabanillas ME, Edeiken-Monroe B, Hu P, Duose D, Wistuba II, Medeiros LJ, Stewart J, Luthra R, Roy-Chowdhuri S. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules. Cancer Cytopathol 127(3):146-160, 2019. e-Pub 2019. PMID: 30620446.
88. *Bashover E, Arriola AG, Joseph CT, Staerkel G, Wang WB, Roy-Chowdhuri S. The Use of Cytologic Material in Melanoma for PD-L1 Immunostaining. Cytopathology 30(1):61-67, 2019. e-Pub 2019. PMID: 30244524.
89. Doxtader EE, Pijuan L, Lepe M, Alex D, Canepa M, Deeken AH, Gibier JB, Jain D, Janaki N, Jelinek A, Kumar S, Labiano T, L'Imperio V, Michael C, Pagni F, Panizo A, Quintana LM, Roy-Chowdhuri S, Sanchez-Font A, Skipper DC, Spruill LS, Torous V, Wu RI, Sauter JL, Mukhopadhyay S. Displaced Cartilage Within Lymph Node Parenchyma is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA. Am J Surg Pathol. e-Pub 2018. PMID: 30475256.
90. *Arriola AGP, Bashover E, Joseph C, Staerkel G, Wang WL, Roy-Chowdhuri S. The usefulness of various cytologic specimen preparations for PD-L1 immunostaining in non-small cell lung carcinoma. J Am Soc Cytopathol 7(6):324-332, 2018. e-Pub 2018. PMID: 31043303.
91. Chen H, Luthra R, Patel KP, Routbort M, Rashid A, Roy-Chowdhuri S, Lazar A, Broaddus R, Manekia J, Singh RR, Yemelyanova A. Challenges in next generation sequencing analysis of somatic mutations in transplant patients. Cancer Genet 226-227:17-22, 2018. e-Pub 2018. PMID: 30005850.
92. Ghosh S, Roy-Chowdhuri S, Kang K, Im SH, Rudra D. The transcription factor Foxp1 preserves integrity of an active Foxp3 locus in extrathymic Treg cells. Nat Commun 9(1):4473, 2018. e-Pub 2018. PMID: 30367168.
93. Jain D, Roy-Chowdhuri S. Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review. Arch Pathol Lab Med 142(9):1127-1133, 2018. e-Pub 2018. PMID: 29547001.
94. Roy-Chowdhuri S, Mehrotra M, Bolivar AM, Kanagal-Shamanna R, Barkoh BA, Hannigan B, Zalles S, Ye W, Duose D, Broaddus R, Staerkel G, Wistuba I, Medeiros LJ, Luthra R. Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling. Mod Pathol 31(7):1036-1045, 2018. e-Pub 2018. PMID: 29463880.
95. *Smith AL, Williams MD, Stewart J, Wang WL, Krishnamurthy S, Cabanillas ME, Roy-Chowdhuri S. Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma. Cancer Cytopathol 126(6):406-413, 2018. e-Pub 2018. PMID: 29579361.
96. *Noll B, Wang WL, Gong Y, Zhao J, Kalhor N, Prieto V, Staerkel G, Roy-Chowdhuri S. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations. Cancer Cytopathol 126(5):342-352, 2018. e-Pub 2018. PMID: 29499101.
97. Thunnissen E, Allen TC, Adam J, Aisner DL, Beasley MB, Borczuk AC, Cagle PT, Capelozzi VL, Cooper W, Hariri LP, Kern I, Lantuejoul S, Miller R, Mino-Kenudson M, Radonic T, Raparia K, Rekhtman N, Roy-Chowdhuri S, Russell P, Schneider F, Sholl LM, Tsao MS, Vivero M, Yatabe Y. Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med 142(3):408-419, 2018. e-Pub 2018. PMID: 28686497.
98. Mizrak Kaya D, Nogueras-González GM, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani MS, Matamoros A, Thomas I, Lin Q, Badgwell BD, Ajani JA. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J Surg Oncol 117(4):678-684, 2018. e-Pub 2018. PMID: 29205363.
99. Fujii T, Matsuda N, Kono M, Harano K, Chen H, Luthra R, Roy-Chowdhuri S, Sahin AA, Wathoo C, Joon AY, Tripathy D, Meric-Bernstam F, Ueno NT. Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer. Eur J Cancer 89:64-71, 2018. e-Pub 2018. PMID: 29232568.
100. Subbiah IM, Tsimberidou A, Subbiah V, Janku F, Roy-Chowdhuri S, Hong DS. Next generation sequencing of carcinoma of unknown primary reveals novel combinatorial strategies in a heterogeneous mutational landscape. Oncoscience 4(5-6):47-56, 2017. e-Pub 2017. PMID: 28781987.
101. Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, Bihl M, Bubendorf L, Salto-Tellez M, de Biase D, Tallini G, Hwang DH, Sholl LM, Luthra R, Weynand B, Vander Borght S, Missiaglia E, Bongiovanni M, Stieber D, Vielh P, Schmitt F, Rappa A, Barberis M, Pepe F, Pisapia P, Serra N, Vigliar E, Bellevicine C, Fassan M, Rugge M, de Andrea CE, Lozano MD, Basolo F, Fontanini G, Nikiforov YE, Kamel-Reid S, da Cunha Santos G, Nikiforova MN, Roy-Chowdhuri S, Troncone G, Meeting Group MC. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens. Cancer. e-Pub 2017. PMID: 28475299.
102. Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani J, Badgwell BD. Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer. Ann Surg Oncol 24(4):960-965, 2017. e-Pub 2017. PMID: 27778127.
103. *McCroskey Z, Staerkel G, Roy-Chowdhuri S. Utility of BRCA1-associated protein 1 immunoperoxidase stain to differentiate benign versus malignant mesothelial proliferations in cytologic specimens. Diagn Cytopathol 45(4):312-319, 2017. e-Pub 2017. PMID: 28205427.
104. Chen H, Singh RR, Lu X, Huo L, Yao H, Aldape K, Abraham R, Virani S, Mehrotra M, Mishra BM, Bousamra A, Albarracin C, Wu Y, Roy-Chowdhuri S, Kanagal-Shamanna R, Routbort MJ, Medeiros LJ, Patel KP, Broaddus R, Sahin A, Luthra R. Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray. Oncotarget 8(7):10845-10857, 2017. e-Pub 2017. PMID: 28125801.
105. Roy-Chowdhuri S, Chen H, Singh RR, Krishnamurthy S, Patel KP, Routbort MJ, Manekia J, Barkoh BA, Yao H, Sabir S, Broaddus RR, Medeiros LJ, Staerkel G, Stewart J, Luthra R. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. Mod Pathol. e-Pub 2017. PMID: 28084342.
106. Basho RK, Gagliato DM, Ueno NT, Wathoo C, Chen H, Shariati M, Wei C, Alvarez RH, Moulder SL, Sahin AA, Roy-Chowdhuri S, Chavez-MacGregor M, Litton JK, Valero V, Luthra R, Zeng J, Shaw KR, Mendelsohn J, Mills GB, Tripathy D, Meric-Bernstam F. Clinical outcomes based on multigene profiling in metastatic breast cancer patients. Oncotarget, 2016. e-Pub 2016.
107. Layfield LJ, Roy-Chowdhuri S, Baloch Z, Ehya H, Geisinger K, Hsiao SJ, Lin O, Lindeman NI, Roh M, Schmitt F, Sidiropoulos N, VanderLaan PA. Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology. Diagn Cytopathol, 2016. e-Pub 2016. PMID: 27561242.
108. Sholl LM, Aisner DL, Allen TC, Beasley MB, Cagle PT, Capelozzi VL, Dacic S, Hariri LP, Kerr KM, Lantuejoul S, Mino-Kenudson M, Raparia K, Rekhtman N, Roy-Chowdhuri S, Thunnissen E, Tsao M, Vivero M, Yatabe Y. Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med 140(8):825-9, 2016. e-Pub 2016. PMID: 27195432.
109. Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Survival rates in T1 and T2 gastric cancer: A Western report. J Surg Oncol. e-Pub 2016. PMID: 27439746.
110. Raparia K, Aisner DL, Allen TC, Beasley MB, Borczuk A, Cagle PT, Capelozzi V, Dacic S, Hariri LP, Kerr KM, Lantuejoul S, Mino-Kenudson M, Rekhtman N, Roden AC, Roy-Chowdhuri S, Sholl L, Smith ML, Thunnissen E, Tsao MS, Yatabe Y. Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. e-Pub 2016. PMID: 27441784.
111. Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD. Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer. Ann Surg Oncol. e-Pub 2016. PMID: 27384751.
112. Roy-Chowdhuri S, Stewart J. Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing-The MD Anderson Experience. Arch Pathol Lab Med. e-Pub 2016. PMID: 27333361.
113. Mihalek AD, Haney C, Merino M, Roy-Chowdhuri S, Moss J, Olivier KN. Exercise-induced haemoptysis as a rare presentation of a rare lung disease. Thorax. e-Pub 2016. PMID: 27272655.
114. Koduru P, Khurana S, Gornals JB, Varas M, Roy-Chowdhuri S, Bhutani MS. Pancreatic neuroendocrine tumor masquerading as metastasis in a patient with esophageal cancer: Diagnosis by endoscopic ultrasound‑guided fine‑needle aspiration. Journal of Digestive Endoscopy 7(2):80-82, 2016. e-Pub 2016.
115. Roy-Chowdhuri S, Aisner DL, Allen TC, Beasley MB, Borczuk A, Cagle PT, Capelozzi V, Dacic S, da Cunha Santos G, Hariri LP, Kerr KM, Lantuejoul S, Mino-Kenudson M, Moreira A, Raparia K, Rekhtman N, Sholl L, Thunnissen E, Tsao MS, Vivero M, Yatabe Y. Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. e-Pub 2016. PMID: 27081878.
116. Goswami RS, Luthra R, Singh RR, Patel KP, Routbort MJ, Aldape KD, Yao H, Dang HD, Barkoh BA, Manekia J, Medeiros LJ, Roy-Chowdhuri S, Stewart J, Broaddus RR, Chen H. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors. Am J Clin Pathol 145(2):222-37, 2016. e-Pub 2016. PMID: 27124905.
117. Sholl LM, Aisner DL, Allen TC, Beasley MB, Borczuk AC, Cagle PT, Capelozzi V, Dacic S, Hariri L, Kerr KM, Lantuejoul S, Mino-Kenudson M, Raparia K, Rekhtman N, Roy-Chowdhuri S, Thunnissen E, Tsao MS, Yatabe Y. Programmed Death Ligand 1 Immunohistochemistry- A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. e-Pub 2016. PMID: 26780537.
118. Roy-Chowdhuri S, Chow CW, Kane MK, Yao H, Wistuba II, Krishnamurthy S, Stewart J, Staerkel G. Optimizing the DNA yield for molecular analysis from cytologic preparations. Cancer Cytopathology. e-Pub 2015.
119. Roy-Chowdhuri S, de Melo Gagliato D, Routbort MJ, Patel KP, Singh RR, Broaddus R, Lazar AJ, Sahin A, Alvarez RH, Moulder S, Wheler JJ, Janku F, Gonzalez-Angulo AM, Chavez-MacGregor M, Valero V, Ueno NT, Mills G, Mendelsohn J, Yao H, Aldape K, Luthra R, Meric-Bernstam F. Multigene Clinical Mutational Profiling of Breast Carcinoma Using Next-Generation Sequencing. American Journal of Clinical Pathology 144(5):713-721, 2015. e-Pub 2015.
120. Sen S, Kawahara B, Gupta D, Tsai R, Khachatryan M, Roy-Chowdhuri S, Bose S, Yoon A, Faull K, Farias-Eisner R, Chaudhuri G. Role of cystathionine β-synthase in human breast Cancer. Free Radic Biol Med 86:228-38, 2015. e-Pub 2015. PMID: 26051168.
121. Janku F, Claes B, Huang HJ, Falchook GS, Devogelaere B, Kockx M, Bempt IV, Reijans M, Naing A, Fu S, Piha-Paul SA, Hong DS, Holley VR, Tsimberidou AM, Stepanek VM, Patel SP, Kopetz ES, Subbiah V, Wheler JJ, Zinner RG, Karp DD, Luthra R, Roy-Chowdhuri S, Sablon E, Meric-Bernstam F, Maertens G, Kurzrock R. BRAF mutation testing with a rapid, fully integrated molecular diagnostics system. Oncotarget 6(29):26886-94, 2015. e-Pub 2015. PMID: 26330075.
122. Roy-Chowdhuri S, Goswami RS, Chen H, Patel KP, Routbort MJ, Singh RR, Broaddus RR, Barkoh BA, Manekia J, Yao H, Medeiros LJ, Staerkel G, Luthra R, Stewart J. Factors affecting the success of next-generation sequencing in cytology specimens. Cancer Cytopathol. e-Pub 2015. PMID: 26230354.
123. Badgwell B, Roy-Chowdhuri S, Chiang YJ, Matamoros A, Blum M, Fournier K, Mansfield P, Ajani J. Long-term survival in patients with metastatic gastric and gastroesophageal cancer treated with surgery. J Surg Oncol 111(7):875-81, 2015. e-Pub 2015. PMID: 25872485.
124. Jardim DL, de Melo Gagliato D, Falchook G, Zinner R, Wheler JJ, Janku F, Subbiah V, Piha-Paul SA, Fu S, Tannir N, Corn P, Tang C, Hess K, Roy-Chowdhuri S, Kurzrock R, Meric-Bernstam F, Hong DS. MET Abnormalities in Patients With Genitourinary Malignancies and Outcomes With c-MET Inhibitors. Clin Genitourin Cancer 13(1):e19-26, 2015. e-Pub 2015. PMID: 25087088.
125. Goswami RS, Patel KP, Singh RR, Meric-Bernstam F, Kopetz S, Subbiah V, Alvarez RH, Davies MA, Jabbar KJ, Roy Chowdhuri S, Lazar AJ, Medeiros LJ, Broaddus RR, Luthra R, Routbort MJ. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors. Clin Cancer Res. e-Pub 2015. PMID: 25695693.
126. Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2015. PMID: 25148578.
127. Jardim DL, Tang C, Gagliato Dde M, Falchook GS, Hess K, Janku F, Fu S, Wheler JJ, Zinner RG, Naing A, Tsimberidou AM, Holla V, Li MM, Roy-Chowdhuri S, Luthra R, Salgia R, Kurzrock R, Meric-Bernstam F, Hong DS. Analysis of 1,115 Patients Tested for MET Amplification and Therapy Response in the MD Anderson Phase I Clinic. Clin Cancer Res 20(24):6336-45, 2014. e-Pub 2014. PMID: 25326232.
128. *Falk NK, Weissferdt A, Habra MA, Roy-Chowdhuri S. Adrenocorticotropic hormone-producing thymic neuroendocrine carcinoma with oncocytic features: A case report and review of literature. Diagn Cytopathol. e-Pub 2014. PMID: 25354884.
129. Roberts NJ, Zhang L, Janku F, Collins A, Bai RY, Staedtke V, Rusk AW, Tung D, Miller M, Roix J, Khanna KV, Murthy R, Benjamin RS, Helgason T, Szvalb AD, Bird JE, Roy-Chowdhuri S, Zhang HH, Qiao Y, Karim B, McDaniel J, Elpiner A, Sahora A, Lachowicz J, Phillips B, Turner A, Klein MK, Post G, Diaz LA, Riggins GJ, Papadopoulos N, Kinzler KW, Vogelstein B, Bettegowda C, Huso DL, Varterasian M, Saha S, Zhou S. Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med 6(249):249ra111, 2014. e-Pub 2014. PMID: 25122639.
130. de Melo Gagliato D, Fontes Jardim DL, Falchook G, Tang C, Zinner R, Wheler JJ, Janku F, Subbiah V, Piha-Paul SA, Fu S, Hess K, Roy-Chowdhuri S, Moulder S, Gonzalez-Angulo AM, Meric-Bernstam F, Hong DS. Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit. Clin Breast Cancer. e-Pub 2014. PMID: 25065564.
131. Jardim DL, de Melo Gagliato D, Falchook GS, Janku F, Zinner R, Wheler JJ, Subbiah V, Piha-Paul SA, Fu S, Murphy MB, Ajani J, Tang C, Hess K, Hamilton SR, Roy-Chowdhuri S, Kurzrock R, Meric-Bernstam F, Hong DS. MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit. Oncotarget. e-Pub 2014. PMID: 24742823.
132. Kanagal-Shamanna R, Portier BP, Singh RR, Routbort MJ, Aldape KD, Handal BA, Rahimi H, Reddy NG, Barkoh BA, Mishra BM, Paladugu AV, Manekia JH, Kalhor N, Chowdhuri SR, Staerkel GA, Medeiros LJ, Luthra R, Patel KP. Next-generation sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics. Mod Pathol 27(2):314-27, 2014. e-Pub 2014. PMID: 23907151.
133. Jardim DL, Wheler JJ, Hess K, Tsimberidou AM, Zinner R, Janku F, Subbiah V, Naing A, Piha-Paul SA, Westin SN, Roy-Chowdhuri S, Meric-Bernstam F, Hong DS. FBXW7 Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors. PLoS One 9(2):e89388, 2014. e-Pub 2014. PMID: 24586741.
134. Erdag, G, Chowdhuri R, S, Fetsch, PErickson, D, Hughes, M S, Filie, A C. KBA.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma. Diagn Cytopathol. e-Pub 2013.
135. Tangrea MA, Hipp JD, Armani MD, Hanson JC, Rodriguez-Canales J, Blacklert AR, Roy-Chowdhuri S, Xi L, Raffeld M, O'Flaherty N, Markey SP, Filie AC, Cheng J, Morgan NY, Pohida TJ, Bonner RF, Balis U, Emmert-Buck MR. Advanced microdissection technologies with potential clinical applications. Journal of Molecular Diagnostics 14(6):739, 2012. e-Pub 2012.
136. Chowdhuri SR, Fetsch P, Squires J, Kohn E, Filie AC. Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: A case report with brief review of immunomarkers. Diagn Cytopathol. e-Pub 2012. PMID: 23161830.
137. Arcila ME, Chaft JE, Nafa K, Roy-Chowdhuri S, Lau C, Zaidinski M, Paik PK, Zakowski MF, Kris MG, Ladanyi M. Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas. Clin Cancer Res 18(18):4910-8, 2012. e-Pub 2012. PMID: 22761469.
138. Chowdhuri SR, Xi L, Pham TH, Hanson J, Rodriguez-Canales J, Berman A, Rajan A, Giaccone G, Emmert-Buck M, Raffeld M, Filie AC. EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection. Mod Pathol 25(4):548-55, 2012. e-Pub 2012. PMID: 22157931.
139. Roy Chowdhuri S, Hanson J, Cheng J, Rodriguez-Canales J, Fetsch P, Balis U, Filie AC, Giaccone G, Emmert-Buck MR, Hipp JD. Semiautomated laser capture microdissection of lung adenocarcinoma cytology samples. Acta Cytol 56(6):622-31, 2012. e-Pub 2012. PMID: 23207440.
140. Gill RK, Yang SH, Meerzaman D, Mechanic LE, Bowman ED, Jeon HS, Roy Chowdhuri S, Shakoori A, Dracheva T, Hong KM, Fukuoka J, Zhang JH, Harris CC, Jen J. Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer. Oncogene 30(35):3784-91, 2011. e-Pub 2011. PMID: 21532627.
141. Hipp J, Cheng J, Pantanowitz L, Hewitt S, Yagi Y, Monaco J, Madabhushi A, Rodriguez-Canales J, Hanson J, Roy-Chowdhuri S, Filie AC, Feldman MD, Tomaszewski JE, Shih NN, Brodsky V, Giaccone G, Emmert-Buck MR, Balis UJ. Image microarrays (IMA): Digital pathology's missing tool. J Pathol Inform 2:47, 2011. e-Pub 2011. PMID: 22200030.
142. Moriyama B, Torabi-Parizi P, Pratt AK, Henning SA, Pennick G, Shea YR, Roy Chowdhuri S, Rinaldi MG, Barrett AJ, Walsh TJ. Pharmacokinetics of liposomal amphotericin B in pleural fluid. Antimicrob Agents Chemother 54(4):1633-5, 2010. e-Pub 2010. PMID: 20086161.
143. Hong KM, Yang SH, Chowdhuri SR, Player A, Hames M, Fukuoka J, Meerzaman D, Dracheva T, Sun Z, Yang P, Jen J. Inactivation of LLC1 gene in nonsmall cell lung cancer. Int J Cancer 120(11):2353-8, 2007. e-Pub 2007. PMID: 17304513.
144. Roy Chowdhuri S, Crum T, Woollard A, Aslam S, Okkema PG. The T-box factor TBX-2 and the SUMO conjugating enzyme UBC-9 are required for ABa-derived pharyngeal muscle in C. elegans. Dev Biol 295(2):664-77, 2006. e-Pub 2006. PMID: 16701625.

Invited Articles

1. VanderLaan PA, Roy-Chowdhuri S, Griffith CC, Weiss VL, Booth CN. Molecular testing of cytology specimens: overview of assay selection with focus on lung, salivary gland, and thyroid testing. J Am Soc Cytopathol 11(6):403-414, 2022. e-Pub 2022. PMID: 36184436.
2. Gan, Q, Roy Chowdhuri S. Specimen Considerations in Molecular Oncology Testing. Clinics in Laboratory Medicine, 2022. e-Pub 2022.
3. Roy-Chowdhuri S. A new guideline from the College of American Pathologists to improve the adequacy of thoracic small specimens for ancillary studies. Cancer Cytopathol 128(10):690-692, 2020. e-Pub 2020. PMID: 32520433.
4. VanderLaan PA, Roy-Chowdhuri S. Current and future trends in non-small cell lung cancer biomarker testing: The American experience. Cancer Cytopathol 128(9):629-636, 2020. e-Pub 2020.
5. Gilbert CR, Wahidi MM, Yarmus LB, Roy-Chowdhuri S, Jr PN. Key Highlights for the College of American Pathology Statement on Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies, 2020. e-Pub 2020.
6. Roy-Chowdhuri S. Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer. Transl Lung Cancer Res 9(3):898-905, 2020. e-Pub 2020.
7. Gan Q, Roy-Chowdhuri S. Small but powerful: the promising role of small specimens for biomarker testing. J Am Soc Cytopathol, 2020. e-Pub 2020.
8. Roy-Chowdhuri S, Pisapia P, Salto-Tellez M, Savic S, Nacchio M, de Biase D, Tallini G, Troncone G, Schmitt F. Invited review-next-generation sequencing: a modern tool in cytopathology. Virchows Arch. e-Pub 2019. PMID: 30877381.
9. Roy-Chowdhuri S. Molecular testing of residual cytology samples: Rethink, reclaim, repurpose. Cancer Cytopathol. e-Pub 2018. PMID: 30317690.
10. Roy-Chowdhuri S. Advances in Molecular Testing Techniques in Cytologic Specimens. Surg Pathol Clin 11(3):669-677, 2018. e-Pub 2018.
11. Fuller, MY, Roy-Chowdhuri S. Social media expands the reach of the 2017 ASC Annual Meeting. Journal of the American Society of Cytopathology 7(4):219-223, 2017. e-Pub 2017.
12. Madrigal E, Jiang XS, Roy-Chowdhuri S. The professional Twitter account: creation, proper maintenance, and continuous successful operation. Diagn Cytopathol 45(7):621-628, 2017. e-Pub 2017. PMID: 28398702.
13. Roy-Chowdhuri S, Roy S, Monaco SE, Routbort MJ, Pantanowitz L. Big data from small samples: Informatics of next-generation sequencing in cytopathology. Cancer. e-Pub 2016. PMID: 27918649.
14. Singh C, Roy-Chowdhuri S. Quantitative Real-Time PCR: Recent Advances. Methods Mol Biol 1392:161-76, 2016. e-Pub 2016. PMID: 26843055.
15. Chen H, Luthra R, Goswami RS, Singh RR, Roy-Chowdhuri S. Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ Malignancies. Cancers (Basel) 7(3):1699-715, 2015. e-Pub 2015. PMID: 26343728.
16. Luthra R, Chen H, Roy-Chowdhuri S, Singh RR. Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges. Cancers (Basel) 7(4):2023-36, 2015. e-Pub 2015. PMID: 26473927.
17. Roy-Chowdhuri S, Krishnamurthy S. The role of cytology in the era of HPV-related head and neck carcinoma. Semin Diagn Pathol. e-Pub 2014. PMID: 25638437.

Review Articles

1. Hamidi, S, Maniakas, A, Akhave, NS, Banuchi, VE, Busaidy, NL, Dadu, R, Ferrarotto, R, Guise, TA, Hofmann, M, Hosseini, SM, Hu, MI, Iyer, PC, Mansour, M, Marczyk, VR, Roy Chowdhuri, S, Sherman, SI, Sousa, LG, Wang, RJ, Williams, MD, Zafereo, M, Waguespack, SG, Cabanillas, ME. Characterization of Advanced RAS-driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues. Journal of Clinical Endocrinology and Metabolism 111(2):471-483, 2026. e-Pub 2026. PMID: 40568752.
2. Lee, J, Chen, F, Lopez-Beltran, A, Necchi, A, Cimadamore, A, Spiess, PE, Li, R, Roy Chowdhuri, S, Montironi, R, Golijanin, D, Luchini, C, Cheng, L. Urinary Tumor DNA–based Liquid Biopsy in Bladder Cancer Management. European Urology Focus 11(6):978-990, 2025. e-Pub 2025. PMID: 40753029.
3. Roy-Chowdhuri S. The Bridge: Supernatant Derived From Cytological Sample Preparations. Cytopathology 36(3):222-227, 2025. e-Pub 2025. PMID: 39921463.
4. Salah HT, Yang RK, Roy-Chowdhuri S, Ross MI, Aung PP, Rothrock AT, Torres-Cabala CA, Curry JL, Prieto VG, Nagarajan P, Cho WC. Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review. J Cutan Pathol 51(6):407-414, 2024. e-Pub 2024. PMID: 38444194.
5. Roy Chowdhuri, S. Molecular Pathology of Lung Cancer. Clinics in Laboratory Medicine 44(2):137-147, 2024. e-Pub 2024. PMID: 38821637.
6. Passaro A, Al Bakir M, Hamilton EG, Diehn M, André F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell 187(7):1617-1635, 2024. e-Pub 2024. PMID: 38552610.
7. Kerr KM, Bubendorf L, Lopez-Rios F, Khalil F, Roy-Chowdhuri S, Joubert P, Hartmann A, Guerini-Rocco E, Yatabe Y, Hofman P, Cooper WA, Dacic S. Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists. Histopathology 84(3):429-439, 2024. e-Pub 2024. PMID: 37957137.
8. Canberk S, Field A, Bubendorf L, Chandra A, Cree IA, Engels M, Hiroshima K, Jain D, Kholová I, Layfield L, Mehrotra R, Michael C, Osamura R, Pitman MB, Roy-Chowdhuri S, Satoh Y, VanderLaan P, Zakowski M, Schmitt FC. A brief review of the WHO reporting system for lung cytopathology. J Am Soc Cytopathol 12(4):251-257, 2023. e-Pub 2023. PMID: 37156705.
9. Schmitt FC, Bubendorf L, Canberk S, Chandra A, Cree IA, Engels M, Hiroshima K, Jain D, Kholová I, Layfield L, Mehrotra R, Michael CW, Osamura R, Pitman MB, Roy-Chowdhuri S, Satoh Y, VanderLaan P, Zakowski MF, Field AS. The World Health Organization Reporting System for Lung Cytopathology. Acta Cytol 67(1):80-91. e-Pub 2022. PMID: 36509066.
10. Gan, Q, Roy Chowdhuri, S. Specimen Considerations in Molecular Oncology Testing. Clinics in Laboratory Medicine 42(3):367-383, 2022. e-Pub 2022. PMID: 36150817.
11. Shojaee S, Roy-Chowdhuri S, Safi J, Grosu HB. Cytologic Investigations for the Diagnosis of Malignant Pleural Effusion in Non-small Cell Lung Cancer: State-of-the-art Review for Pulmonologists. J Bronchology Interv Pulmonol 28(4):310-321, 2021. e-Pub 2021. PMID: 34238837.
12. Roy-Chowdhuri S. Molecular Pathology of Lung Cancer. Surg Pathol Clin 14(3):369-377, 2021. e-Pub 2021. PMID: 34373089.
13. Jain D, Roy-Chowdhuri S. Advances in cytology of lung cancer. Semin Diagn Pathol 38(5):109-115, 2021. e-Pub 2021. PMID: 34119361.
14. Roy Chowdhuri, S. Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies. Journal of Molecular Pathology 2(1):23-28, 2021. e-Pub 2021.
15. VanderLaan PA, Roy-Chowdhuri S. Current and future trends in non-small cell lung cancer biomarker testing: The American experience. Cancer Cytopathol 128(9):629-636, 2020. e-Pub 2020. PMID: 32885913.
16. Roy-Chowdhuri S. Immunocytochemistry of cytology specimens for predictive biomarkers in lung cancer. Transl Lung Cancer Res 9(3):898-905, 2020. e-Pub 2020. PMID: 32676355.
17. Bhutani MS, Cazacu IM, Roy-Chowdhuri S, Maitra A, Pishvaian MJ. Upfront molecular profiling of pancreatic cancer patients - An idea whose time has come. Pancreatology. e-Pub 2020. PMID: 32192904.
18. Jain D, Allen TC, Aisner DL, Beasley MB, Cagle PT, Capelozzi VL, Hariri LP, Lantuejoul S, Miller R, Mino-Kenudson M, Monaco SE, Moreira A, Raparia K, Rekhtman N, Roden AC, Roy-Chowdhuri S, da Cunha Santos G, Thunnissen E, Troncone G, Vivero M. Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med 142(2):253-262, 2018. e-Pub 2018. PMID: 28639854.

Professional Educational Materials

1. Reviewer. 2021 FNA-A: FNA of Pancreaticobiliary - Digital Slide Program in Fine-Needle Aspiration. ©2021 College of American Pathologists. Online CME/CE Education Activity, 2021.
2. Roy-Chowdhuri S. 2020 FNA-B: FNA of EBUS/EUS FNA - Digital Slide Program in Fine-Needle Aspiration ©2020 College of American Pathologists, 2020.
3. Editor. 2020 FNA-A: Unusual Variants of Common Tumors FNA - Digital Slide Program in Fine Needle Aspiration ©2020 College of American Pathologists, 2020.
4. Editor. 2019 TICP-B: Touch Imprint/Crush Preparation Program (SAM eligible) ©2019 College of American Pathologists, 2019.
5. Roy-Chowdhuri S. 2019 TICP-A: Touch Imprint/Crush Preparation Program (SAM eligible) ©2019 College of American Pathologist, 2019.
6. Singh C, Roy AJ, Roy-Chowdhuri S. Image-based Cytopathology Reference App on iOS “CytoAtlas”, 2014.

Other Articles

1. Marczyk, VR, Fazeli, S, Dadu, R, Busaidy, NL, Iyer, PC, Hu, MI, Sherman, SI, Hamidi, S, Hosseini, SM, Williams, MD, Ahmed, S, Routbort, MJ, Luthra, R, Roy Chowdhuri, S, San Lucas, FA, Patel, KP, Hong, DS, Zafereo, M, Wang, RJ, Maniakas, A, Waguespack, SG, Cabanillas, ME Erratum. JCO Precision Oncology 9, 2025. PMID: 40632979.

Editorials

1. Roy Chowdhuri, S. An overview of molecular testing in genitourinary malignancies. Urologic Oncology: Seminars and Original Investigations 43(10):533, 2025. PMID: 40930707.
2. Vigliar E, Lozano MD, Roy-Chowdhuri S. Editorial: Advances in Molecular Cytopathology. Front Med (Lausanne) 9:851949, 2022. PMID: 35223934.
3. Troncone G, Roy-Chowdhuri S. Modern Cytopathology: An evolving field. Cytopathology 32(5):560-561, 2021. PMID: 34390522.
4. Roy-Chowdhuri S, Rossi ED. The world of molecular cytopathology: Predictive testing and precision medicine: Highlights from the eighth International Molecular Cytopathology Meeting in Naples, Italy. Cancer Cytopathol 128(9):599-600, 2020. PMID: 32885915.
5. Roy-Chowdhuri S. Tumor-derived cell-free DNA in body cavity effusion supernatants: A promising alternative for genomic profiling. Cancer Cytopathol 128(1):14-16, 2020. PMID: 31750996.
6. Booth AL, Roy-Chowdhuri S. Becoming an Engaged Pathologist. Arch Pathol Lab Med 143(2):149-150, 2019.
7. Roy-Chowdhuri S. Molecular testing of residual cytology samples: Rethink, reclaim, repurpose. Cancer Cytopathol, 2018.
8. Troncone G, Roy-Chowdhuri S. Key Issues in Molecular Cytopathology. Arch Pathol Lab Med 142(3):289-290, 2018.
9. Jiang XS, Madrigal E, Roy-Chowdhuri S. A Twitter primer: Dos and don'ts for cytopathologists. Diagn Cytopathol 45(7):577-579, 2017. PMID: 28397371.
10. Rekhtman N, Roy-Chowdhuri S. Cytology Specimens: A Goldmine for Molecular Testing. Arch Pathol Lab Med 140(11):1189-1190, 2016. PMID: 27788046.
11. Ballester LY, Olar A, Roy-Chowdhuri S. Next-generation sequencing of central nervous systems tumors: the future of personalized patient management. Neuro Oncol 18(3):308-10, 2016. PMID: 26917589.

Abstracts

1. Zhang, Q, Zheng, L, Chen, H, Roy-Chowdhuri, S||B, Hansel, D, Czernia, B, Guo, C. Mutational Profile of Small Cell Carcinoma of the Urinary Bladder, 2024. e-Pub 2024.
2. Sun, B, Guerrouahen, B, Piya, S, Duose, D, Umzunparmak, B, Reddy, N, Famobio, T, Veliyathu JJ, Luu, S, Walters, K, Ninan, S, Meric-Bernstam, F, Luthra, R, Roy-Chowdhuri, S, Wang, (Billy) WL, Wistuba, I, Mantha, G, Chen, H. TROP2 Immunohistochemical Assay in Solid Tumors: Comparison of Interpretation Scoring Assessments by H-Score and Clinical Trials Driven ADC-Score, 2024. e-Pub 2024.
3. Alhussain, A, Roy-Chowdhuri, S, Riben, M, Kundu, U. Evaluating Quality Indicators for Rapid On-site Evaluation Using Telecytology, 2024. e-Pub 2024.
4. Al-Attar, M, Elzamly, S, Zhang, Q, Zheng, L, Chen, H, Roy-Chowdhuri, S, Hansel, D, Czerniak, B, Guo, C. Mutational Profile of Sarcomatoid Urothelial Carcinoma, 2024. e-Pub 2024.
5. Shen, Y, Zheng, L, Zhao, J, Wang, Y, Chen, H, Wei, P, Roy-Chowdhuri, S, Hansel, D, Czerniak, B, Guo, C. Molecular Profile of Micropapillary Urothelial Carcinoma of the Urinary Bladder: An Analysis of 99 Cases by Next Generation Sequencing, 2024. e-Pub 2024.
6. Diks J Tang Z, Altan M, Chen H, Rashid A, Yang RK, Routbort M, Patel KP, Toruner GA, Tang G, Roy-Chowdhuri S. Clinically Actionable Gene Fusion Detection by Next-Generation Sequencing-Based RNA Sequencing in Non-Small Cell Lung Cancer Cytology Specimens: A Single Center Experience with Comparison to Fluorescence in Situ Hybridization, 2023. e-Pub 2023.
7. Dinarvand P, Wang WL, Roy-Chowdhuri S. Utility of SOX11 for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas on Cytological Preparations, 2022. e-Pub 2022.
8. Peyman D, Liu C, Roy-Chowdhuri S. A decade of change: Trends in the practice of cytopathology at a tertiary care cancer center, 2022. e-Pub 2022.
9. Dinarvand P, Liu C, Roy-Chowdhuri S. A Decade of Change: Trends in the Practice of Cytopathology at a Tertiary Cancer Center, 2021. e-Pub 2021.
10. Dinarvand P, Wang W, Roy-Chowdhuri S. Utility of SOX11 as a Diagnostic Marker for Solid Pseudopapillary Neoplasm of Pancreas Using Cytologic Smear Preparations, 2021. e-Pub 2021.
11. Liu Z, Roy-Chowdhuri S. Evaluating PD-L1 in Cytology to Determine Eligibility for Anti-PD-1/PD-L1 Immunotherapy in Patients with Head and Neck Squamous Cell Carcinoma, 2021. e-Pub 2021.
12. Ramani NS, Routbort MJ, Patel KP, Broaddus RR, Chen H, Rashid A, Lazar AJ, Medeiros LJ, Manekia J, Barkoh BA, Dang H, Luthra R, Stewart J, Roy-Chowdhuri S. Utilization of Cytology Smears for NGS-based RNA Fusion Testing Improves Adequacy Rates, 2020. e-Pub 2020.
13. Ramani NS, Routbort MJ, Patel KP, Broaddus RR, Chen H, Rashid A, Lazar AJ, Manekia J, Dang H, Barkoh BA, Mantha G, Medeiros LJ, Luthra R, Roy-Chowdhuri S. Factors Affecting the Success of Clinically Relevant RNA Fusion Assays Using Next‐Generation Sequencing, 2020. e-Pub 2020.
14. Hou T, Landon G, Stewart J, Roy-Chowdhuri S. Risk of Malignancy (ROM) in the Category of “Atypia of Undetermined Significance” versus “Suspicious for Malignancy” for Serous Cavity Effusions: A Tertiary Cancer Center’s Experience, 2020. e-Pub 2020.
15. Jacobi E, Landon G, Broaddus R, Roy-Chowdhuri S. Evaluating MSI/MMR Status using Cytology Specimens to Determine Eligibility for Immunotherapy, 2019. e-Pub 2019.
16. Faber E, Grosu H, Sabir S, San Lucas FA, Barkoh BA, Luthra R, Stewart J, Roy-Chowdhuri S. Adequacy of EBUS-TBNA and CT-FNA Specimens for Biomarker Testing to Determine Eligibility for Immune Checkpoint Inhibitor and Targeted Therapy in Lung Carcinoma Patients, 2019. e-Pub 2019.
17. Roy-Chowdhuri S, Mehrotra M, Bolivar AM, Kanagal-Shamanna R, Barkoh BA, Hannigan B, Zalles S, Ye W, Duose D, Broaddus R, Staerkel G, Wistuba I, Medeiros LJ, Luthra R. Utilizing Discarded Supernatants for Mutation Profiling of Malignant Lung FNA Specimens: "Next Generation" Cytopathology, 2018. e-Pub 2018.
18. Smith AL, Edeiken-Monroe BS, Roy-Chowdhuri S, Krishnamurthy S. Fine Needle Aspiration Cytology of a Large Series of Anaplastic Thyroid Carcinoma, 2017. e-Pub 2017.
19. Smith AL, Williams MD, Cabanillas ME, Stewart J, Wei-Lien W, Krishnamurthy S, Roy-Chowdhuri S. Utility of BRAF V600E Immunoperoxidase Stain in Cytology Preparations of Cell Block and Aspirate Smears in Thyroid Cancers, 2017. e-Pub 2017.
20. Roy-Chowdhuri S, Chen H, Staerkel G, Stewart J. Morphologic Assessment of Cellularity and Tumor Fraction in Concurrently Acquired Cytology Fine Needle Aspiration and Surgical Core Needle Biopsy for Molecular Analysis, 2016. e-Pub 2016.
21. Roy-Chowdhuri S, Routbort MJ, Singh RR, Broaddus R, Lazar A, Rashid A, Chen H, Yemelyanova A, Manekia J, Chen W, Medeiros LJ, Hamilton S, Luthra R, Patel KP. SNP Signature-Based Sample Identification as a Patient Safety Tool in NGS-Based Targeted Oncologic Testing, 2016. e-Pub 2016.
22. Roy-Chowdhuri S, Singh RR, Manekia J, Barkoh BA, Yao H, Krishnamurthy S, Medeiros LJ, Staerkel G, Stewart J, and Luthra R. Comparing Next Generation Sequencing in Concurrently Acquired Cytology Fine Needle Aspirations and Surgical Core Needle Biopsies of Solid Organ Malignancies, 2016. e-Pub 2016.
23. Chen H, Broaddus R, Barkoh BA, Abraham R, Singh R, Luthra R, Roy-Chowdhuri S. Evaluating Pathologist Accuracy in Estimation of Percentage of Malignant Cells, 2016. e-Pub 2016.
24. McCroskey Z, Staerkel G, Roy-Chowdhuri S. Utility of BRCA1-associated protein 1 immunoperoxidase stain in cytology smear/cell block preparations to differentiate benign versus malignant mesothelial proliferations, 2016. e-Pub 2016.
25. Goswami R, Chen H, Patel K, Routbort M, Yao H, Dang H, Barkoh B, Aldape K, Roy Chowdhuri S, Stewart J, Medeiros L, Broaddus R, Singh R, Luthra R. Improving Next-Generation Sequencing (NGS) Success in Solid Tumors, 2015. e-Pub 2015.
26. Kane MK, Chow C, Wistuba I, Stewart J, Staerkel G, Roy-Chowdhuri S. Optimizing DNA Yield for Molecular Analysis from Cytologic Preparations, 2015. e-Pub 2015.
27. Roy-Chowdhuri S, Goswami RS, Chen H, Barkoh BA, Manekia J, Patel KP, Routbort MJ, Singh RR, Broaddus R, Medeiros LJ, Staerkel G, Luthra R, Stewart J. Factors Affecting the Success of Next-Generation Sequencing in Cytology Specimens, 2015. e-Pub 2015.
28. Chen H, Singh R, Huo L, Lu X, Bousamra A, Abraham R, Mehrotra M, Mishra BM, Virani S, Roy Chowdhuri S, Routbort M, Aldape K, Broaddus R, Sahin A, Patel K, Rajyalakshmi L. FGFR1 and EGFR Amplification in Breast Cancer, 2015. e-Pub 2015.
29. Roy Chowdhuri S, Routbort M, Singh RR, Aldape K, Broaddus R, Lazar A, Barkoh BA, Reddy N, Medeiros LJ, Luthra R, Patel KP. The Art and Science of Next Generation Sequencing Data Interpretation: Value of Pattern Recognition and Statistical Analysis in Distinguishing True Mutations from Artifacts, 2014. e-Pub 2014.
30. Roy Chowdhuri S, Routbort M, Patel KP, Singh RR, Broaddus R, Lazar A, Sahin A, Mills G, Mendelsohn J, Meric-Bernstam F, Aldape K, Luthra R. Multi-gene Mutational ProfilingBreast Carcinoma using Next Generation Sequencing (NGS), 2014. e-Pub 2014.
31. Jabbar KJ, Patel K, Ken K, Rajesh S, Russell B, Shaw K, Meric-Bernstam F, Roy-Chowdhuri S, Alex L, Goswami R, Medeiros LJ, Rajalakshmi L, Routbort M. Gene Amplification Patterns Identified by Next Generation Sequencing in a Large Tumor Cohort, 2014. e-Pub 2014.
32. Roy Chowdhuri S, Goswami RS, Chen H, Routbort M, Patel KP, Aldape K, Lazar A, Broaddus R, Singh RR, Luthra R, Kanagal-Shamanna R. Isocitrate Dehydrogenase 1 and 2 (IDH1 and IDH2) Mutations in Solid Organ Malignancies by Next Generation Sequencing, 2014. e-Pub 2014.
33. Singh C, Roy A, Roy-Chowdhuri S. Image-based Cytopathology Reference App on iOS Platform, 2014. e-Pub 2014.
34. Mino B, S R, Gonzalez I, Kiriakova G, Liu H, Fujimoto J, Tang X, Weissferdt A, Kalhor N, Wistuba I, Moran CA, Rodriguez-Canales J. Optimization of a Cell Transfer Technique for Multiple Immunocytochemistry from Single Cytology Smears for Pathology and Translational Research, 2014. e-Pub 2014.
35. Roy Chowdhuri S, Routbort M, Patel KP, Singh RR, Broaddus R, Lazar A, Aldape K, Luthra R, Wistuba I, Simon GR. Using NGS for Mutational Profiling of NSCLC in the Clinical Setting, 2013. e-Pub 2013.
36. Roy Chowdhuri S, Zaidi T, Khanna A, Jiang F, Spitz M, Vaporciyan A, Roth J, Ensor Jr J, Katz RL. 3p22.1 deletions by FISH in non-small cell lung cancer (NSCLC) correlates with loss of β catenin expression and dysregulated cell adhesion, 2013. e-Pub 2013.
37. Roy Chowdhuri S, Routbort M, Patel KP, Kanagal-Shamanna R, Singh RR, Simon G, Broaddus R, Lazar A, Zhuo Z, Aldape K, Luthra R. Multi-gene Mutational Profiling of Lung Carcinoma using Next Generation Sequencing (NGS), 2013. e-Pub 2013.
38. Roy Chowdhuri S, Chaft JE, Nafa K, Kris MG, Zakowski M, Ladanyi M, Arcila MA. Molecular and clinicopathologic characteristics of HER2 mutant lung adenocarcinoma (ADC), 2012. e-Pub 2012.
39. Roy Chowdhuri S, Fetsch P, Hughes MS, Filie AC. KBA.62 and KIT expression patterns in fine-needle aspirates of malignant melanoma metastatic to the liver, 2011. e-Pub 2011.
40. Roy Chowdhuri S, Xi L, Pham T, Hanson J, Giaccone G, Emmert-Buck M, Raffeld M, Filie AC. High sensitivity EGFR and KRAS mutation detection in cytologic preparations enabled by laser capture microdissection (LCM), 2011. e-Pub 2011.
41. Roy Chowdhuri S, Vicens J, Teller L, Linehan WM, Merino MJ. Renal Cancer in Tuberous Sclerosis: An Underdiagnosed Disease? Molecular, IHC and Pathologic Correlation, 2009. e-Pub 2009.
42. Roy Chowdhuri S, Turner M, Lee CR. Cutaneous metastasis of malignant mesothelioma presenting as drug eruption: a case report, 2009. e-Pub 2009.
43. Roy Chowdhuri S, Woollard A, Aslam S, Okkema PG. The T-domain factor TBX-2 and components of the SUMO-conjugating pathway are required for ABa-derived pharyngeal muscle, 2005. e-Pub 2005.
44. Roy Chowdhuri S, Huynh Y, Okkema PG. The C. elegans T-box gene tbx-2 is required for pharyngeal development, 2004. e-Pub 2004.
45. Roy Chowdhuri S, Huynh Y, Okkema PG. The role of tbx-2 in C. elegans pharyngeal development, 2003. e-Pub 2003.
46. Roy Chowdhuri S, Huynh Y, Okkema PG. Understanding the role of tbx-2 in C. elegans pharyngeal development, 2003. e-Pub 2003.
47. Guerrouahen B, Lucas FS, Wang W, Roy-Chowdhuri S, Suchko M, Sun B, Shah KP, Reddy N, Mantha G, Meric-Bernstam F, Chen H. Optimizing TROP2 Immunohistochemistry Scoring by Automated Quantitative Image Analysis for Generating Clinical Trial-Driven IHC Scores. United States and Canadian Academy of Pathology.
48. Alrohaibani A, Sweeney K, Krasniqi R, Ding Q, Huo L, Wu Y, Dhamne S, Luthra R, Lucas FS, Roy-Chowdhuri S, Routbort M, Patel K, Yang R, Arun B, Albarracin C, Chen H. ESR1 Mutated Advanced Breast Cancer: Clinicopathological and Molecular Characteristics. United States and Canadian Academy of Pathology.
49. Dai M, Che H, Iorgulescu B, Alvarez H, Luthra R, Patel K, Rashid A, Sura G, Sweeney K, Toruner G, Yang R, Dang H, Lucas FS, Roy-Chowdhuri S. Unraveling the Nexus: Tumor Mutational Burden, PD-L1 Expression and Oncogene Specific Alterations in Cytology Specimens of Non-Small Cell Lung Cancer. United States and Canadian Academy of Pathology.
50. Ibrahim E, Yang R, Nagarajan P, Sweeney K, Chen H, Roy-Chowdhuri S, Lenskaya V, Aung P, Curry J, Ivan D, Prieto V, Torres-Cabala C, Cho WC. Clinicopathologic and Molecular Characterization of BRAF-Fused Melanomas: A Retrospective Analysis of 9 Cases with 8 Novel Fusions Detected by Next-Generation Sequencing. United States and Canadian Academy of Pathology.
51. Sweeney K, Yang R, Alrohaibani A, Krasniqi R, Roy-Chowdhuri S, Patel K, Routbort M, Albarracin C, Chen H. Recurring Genes in Fusions in Advanced Breast Carcinoma Detected by Next Generation Sequencing: Novel BCR and TMPRSS2 Gene Fusions. United States and Canadian Academy of Pathology.

Book Chapters

1. Roy Chowdhuri S. Molecular Cytopathology. In: Molecular Surgical Pathology. 2nd, 2023.
2. Roy Chowdhuri S. Pancreaticobiliary cytopathology techniques, Ancillary testing. In: WHO Reporting System for Pancreaticobiliary Cytopathology, IAC-IARC-WHO Cytopathology Reporting Systems. 1st, 2022.
3. Roy Chowdhuri S. Lung cytopathology techniques, Ancillary Testing. In: WHO Reporting System for Lung Cytopathology, IAC-IARC-WHO Cytopathology Reporting Systems. 1st, 2022.
4. Roy Chowdhuri S. Molecular Pathology of Lung Cancer. In: Molecular Pathology Surgical Pathology Clinics. Elsevier, 2021.
5. Roy Chowdhuri S, Roy S, Pantanowitz L. Next generation Sequencing. In: Cytology Monograph on Modern Techniques. Karger, 2020.
6. Roy Chowdhuri S, Luthra R, Wistuba II. Diagnostic Molecular Pathology. In: Oncological Surgical Pathology. Springer, 2020.
7. Roy-Chowdhuri S Sidiropoulos N. Recommendations for Ancillary Testing. In: The Papanicolaou Society of Cytopathology System for Reporting Respiratory Cytology. Springer, 2019.
8. Roy Chowdhuri S. Molecular Cytopathology Correlations: Interpretation of Molecular Diagnostic Results. In: Molecular Diagnostics in Cytopathology: A Practical Handbook for the Practicing Pathologist. First. Springer, 2019.
9. Roy Chowdhuri S. Molecular Cytopathology: Final Thoughts and Future Directions. In: Molecular Diagnostics in Cytopathology: A Practical Handbook for the Practicing Pathologist. Springer, 2019.
10. Yang H, Saqi A, Jain D, Roy Chowdhuri S, VanderLaan P. Non Cellular Structures. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
11. Jain D, Roy Chowdhuri S, VanderLaan P. Bronchus. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
12. Roy-Chowdhuri S. Advances in Molecular Testing Techniques in Cytologic Specimens. In: Surg Pathol Clin. 3. Elsevier, 669-677, 2018.
13. VanderLaan P, Saqi A, Roy Chowdhuri S. Pleura. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
14. Roy Chowdhuri S, Saqi A, VanderLaan P. Procedural and Laboratory Artifacts. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
15. Roy Chowdhuri S, Saqi A, Jain D, VanderLaan P. Reactive Changes, Nonspecific Findings, and Age-Related Changes. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
16. Saqi A, Yang H, Jain D, VanderLaan P, Roy Chowdhuri S. Normal Cytology of the Lung and pleura. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
17. VanderLaan P, Roy Chowdhuri S. Blood Vessels and Lymphatics. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
18. Roy Chowdhuri S. Advances in Molecular Testing Techniques in Cytologic Specimens. In: Cytopathology, Surgical Pathology Clinics. Elsevier, 2018.
19. Jain D, VanderLaan P, Roy Chowdhuri S. Alveoli. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
20. Roy Chowdhuri S, VanderLaan P. Bronchioles and Alveolar Ducts. In: Pulmonary Pathology: An Atlas and Text. 3rd edition, 2018.
21. Singh C, Roy Chowdhuri S. Advances in real time quantitative PCR. In: Clinical applications of PCR. 3rd Edition, 2016.

Books (edited and written)

1. Ruiz-Cordero, R, Roy Chowdhuri, S. Molecular Cytopathology, 2023.
2. Roy Chowdhuri S. Molecular Cytopathology, in Molecular Surgical Pathology. Ed(s) 2nd, 2023.
3. Roy Chowdhuri S. Pancreaticobiliary cytopathology techniques, Ancillary testing in WHO Reporting System for Pancreaticobiliary Cytopathology, IAC-IARC-WHO Cytopathology Reporting Systems. Ed(s) 1st, 2022.
4. Roy Chowdhuri S. Associate Editor, WHO Reporting System for Lung Cytopathology, IAC-IARC-WHO Cytopathology Reporting Systems. Ed(s) 1st, 2022.
5. Roy Chowdhuri S. Lung cytopathology techniques, Ancillary Testing in WHO Reporting System for Lung Cytopathology, IAC-IARC-WHO Cytopathology Reporting Systems. Ed(s) 1st, 2022.
6. Roy Chowdhuri S. Molecular Pathology of Lung Cancer in Molecular Pathology, 2021.
7. Roy Chowdhuri S. Editor, Molecular Diagnostics in Cytopathology: A Practical Handbook for the Practicing Pathologist. Springer, 2019.
8. Roy Chowdhuri S. Associate Editor, Pulmonary Pathology: An Atlas and Text. Ed(s) 3rd, 2018.
9. Roy Chowdhuri S. Associate Editor Section: Artifacts and Age-Related Changes, 2018.
10. Roy Chowdhuri S. Associate Editor Section: Normal Cytology and Histology, 2018.

Letters to the Editor

1. Badgwell, BD, Estrella, JS, Roy Chowdhuri, S, Ikoma, N, Blum Murphy, M, Ajani, JA, Mansfield, PF. Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer 31: 2824-2825, 2024.